Henry Schein Appoints Frederick Lowery as New CEO, Stanley Bergman Transitions to Chairman
Summary
Henry Schein, Inc. announced the appointment of Frederick Lowery as its new Chief Executive Officer, effective March 2, 2026, with current CEO Stanley Bergman transitioning to Chairman of the Board.
Key Events
-
New CEO Appointed
Frederick Lowery, formerly Executive Vice President and President at Thermo Fisher Scientific Inc., has been appointed Chief Executive Officer, effective March 2, 2026. He will also join the Board of Directors.
-
Leadership Transition
Current CEO Stanley M. Bergman will transition to Chairman of the Board, ensuring a planned and smooth succession after 35 years as CEO.
-
Executive Compensation Package
Mr. Lowery's compensation includes an annual base salary of $1.25 million, a target annual bonus of 150% of base salary, $10 million in annual equity awards for 2026, a one-time cash bonus of $1.184 million, and a $2.5 million sign-on equity award.
-
Corporate Governance Changes
The company's by-laws were amended to eliminate the requirement for a President and permit the CEO to not also hold the President or Chairman roles, aligning with the new leadership structure.
Analysis
This 8-K filing announces a significant leadership transition for Henry Schein, Inc., with Frederick Lowery appointed as the new Chief Executive Officer, effective March 2, 2026. The current CEO, Stanley Bergman, will transition to Chairman of the Board, ensuring a smooth and planned succession. Lowery's background at Thermo Fisher Scientific, a major player in the healthcare industry, brings valuable experience in scaling complex businesses and driving growth. The substantial compensation package, including a $1.25 million base salary, a target annual bonus of 150% of base salary, and $13.684 million in initial equity and one-time cash bonuses, reflects the importance of the role. Amendments to the company's by-laws and executive severance plan are administrative changes to support this new leadership structure and provide a standard safety net for the incoming CEO.
At the time of this filing, HSIC was trading at $78.50 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $9.3B. The 52-week trading range was $60.56 to $82.49. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.